Ophthalmology

Quarter of partially-sighted have unmet needs

Almost a quarter of people with severe sight loss in the UK are going without the treatment they need, according to a new study being presented at the World Congress on Public Health today.

Ophthalmology

Blindness and sight loss to double by 2050

Blindness and severe vision impairment is predicted to affect almost 900 million people worldwide by 2050—up from around 338 million today, according to a new pre-print study accepted by The Lancet and highlighted on World ...

Genetics

Gene therapy targets inner retina to combat blindness

Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease. Adeno-associated viral (AAV)-mediated expression of the human CLN3 gene led to significant survival ...

Diseases, Conditions, Syndromes

Glaucoma patients worry about managing disease during pandemic

(HealthDay)—Glaucoma patients are concerned about managing their condition during the COVID-19 lockdowns, according to the results of a survey released by the Glaucoma Research Foundation (GRF).

Ophthalmology

New eye drops may prevent a common cause of blindness

Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults worldwide.

page 12 from 34